Randomized Controlled Phase 3 Trial of Remestemcel-L for Reduced Mortality in COVID-19 Acute Respiratory Distress Syndrome Surpasses 50% Enrollment

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability